[1] 高颖,罗小林,廖鹏飞,等. LncRNA NORAD通过miR-199a-3p调控ZNF217对非小细胞肺癌细胞增殖、凋亡及化疗敏感性的影响[J]. 中国肺癌杂志,2023,26(7):479-486. DOI:10.3779/j.issn.1009-3419.2023.102.27.
[2] Yang K, Zhang W, Zhong L, et al. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer[J]. Cell Death Differ, 2023,30(6):1533-1549. DOI: 10.1038/s41418-023-01160-x.
[3] Dong Q, Long X, Cheng J, et al. LncRNA GAS5 suppresses ovarian cancer progression by targeting the miR-96-5p/PTEN axis[J]. Ann Transl Med, 2021,9(24):1770. DOI: 10.21037/atm-21-6134.
[4] Filippova EA, Fridman MV, Burdennyy AM, et al. Long noncoding RNA GAS5 in breast cancer: epigenetic mechanisms and biological functions[J]. Int J Mol Sci, 2021,22(13):6810. DOI: 10.3390/ijms22136810.
[5] Wang Y, Zhai S, Xing J, et al. LncRNA GAS5 promotes abdominal aortic aneurysm formation through regulating the miR-185-5p/ADCY7 axis[J]. Anticancer Drugs, 2022,33(3):225-234. DOI: 10.1097/CAD.0000000000001090.
[6] Tang L, Wang S, Wang Y, et al. LncRNA-UCA1 regulates lung adenocarcinoma progression through competitive binding to miR-383[J]. Cell Cycle, 2023,22(2):213-228. DOI: 10.1080/15384101.2022.2111929.
[7] Ding Z, Ying W, He Y, et al. lncRNA-UCA1 in the diagnosis of bladder cancer: a meta-analysis[J]. Medicine (Baltimore), 2021,100(11):e24805. DOI: 10.1097/MD.0000000000024805.
[8] 周箭,黄纯兰,刘恒伟,等. miR-29a-3p靶向肝癌衍生生长因子抑制E6-1细胞增殖并促进其凋亡[J]. 中国实验血液学杂志,2022,30(6):1650-1654. DOI:10.19746/j.cnki.issn1009-2137.2022.06.004.
[9] 中华医学会,中华医学会肿瘤学分会,中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2019版)[J]. 中华肿瘤杂志,2020,42(4):257-287. DOI:10.3760/cma.j.cn112152- 20200120-00049.
[10] He Y, Jiang X, Duan L, et al. LncRNA PKMYT1AR promotes cancer stem cell maintenance in non-small cell lung cancer via activating Wnt signaling pathway[J]. Mol Cancer, 2021,20(1):156. DOI: 10.1186/s12943-021- 01469-6.
[11] Ni J, Zhang X, Li J, et al. Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts[J]. Cell Death Dis, 2021,12(7):662. DOI: 10.1038/s41419-021-03928-w.
[12] Zhu Q, Zhang C, Qu T, et al. MNX1-AS1 promotes phase separation of IGF2BP1 to drive c-myc-mediated cell-cycle progression and proliferation in lung cancer[J]. Cancer Res, 2022,82(23):4340-4358. DOI: 10.1158/0008-5472.CAN-22-1289.
[13] Yin H, Chen L, Piao S, et al. M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1/SMAD2/SMAD3 pathway[J]. Cell Death Differ, 2023,30(3):605-617. DOI: 10.1038/s41418-021-00888-8.
[14] Shen J, Liang C, Su X, et al. Dysfunction and ceRNA network of the tumor suppressor miR-637 in cancer development and prognosis[J]. Biomark Res, 2022,10(1):72. DOI: 10.1186/s40364-022-00419-8.
[15] Chen H, Wang L, Liu J, et al. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2/NAMPT axis[J]. Cancer Biol Ther, 2023,24(1):2223377. DOI: 10.1080/15384047.2023.2223377.
[16] 王庆华,蔡宏剑,马明超,等. 非小细胞肺癌患者血清长链非编码RNA-GAS5、微小RNA-96-5p的表达及临床意义[J]. 中国医刊,2021,56(4):386-390. DOI:10.3969/j.issn. 1008-1070.2021.04.010.
[17] Ma J, Miao H, Zhang H, et al. LncRNA GAS5 modulates the progression of non-small cell lung cancer through repressing miR-221-3p and up-regulating IRF2[J]. Diagn Pathol, 2021,16(1):46. DOI: 10.1186/s13000-021- 01108-0.
[18] Al Mourgi M, El Askary A, Gharib AF, et al. Circulating long non-coding RNA GAS5: a non-invasive molecular marker for prognosis, response to treatment and survival in non-small cell lung cancer[J]. Cancer Invest, 2021,39(6-7):505-513. DOI: 10.1080/07357907.2021.1928167.
[19] Wan Y, Yao D, Fang F, et al. LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival[J]. BMC Cancer, 2021,21(1):104. DOI: 10.1186/s12885-020-07767-4.
[20] Shi W, Ling L, Li C, et al. Correction: LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway[J]. J Cancer Res Clin Oncol, 2023,149(3):1355. DOI: 10.1007/s00432- 022-04568-z.
[21] Hubert P, Roncarati P, Demoulin S, et al. Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy[J]. J Immunother Cancer, 2021,9(3):e001966. DOI: 10.1136/jitc-2020-001966.
[22] 徐绍娜,徐晓焱,祝慧慧,等. lncRNA UCA1通过miR-513a-3p/CYP1B1生物学轴促进人肺癌细胞增殖和迁移的机制研究[J]. 中国现代医药杂志,2022,24(8):13-18. DOI:10.3969/j.issn.1672-9463.2022.08.003.
[23] 闫燕艳,郭乔如,范欣悦,等. 鸦胆亭上调miR-29a-3p抑制非小细胞肺癌H1299细胞增殖、迁移与侵袭[J]. 药学学报,2021,56(2):520-527. DOI:10.16438/j.0513-4870. 2020-1620.
[24] 王慧,韦小夏,马志敏,等. 吸烟和健康饮食评分在文化程度与肺癌发病风险关联中的中介效应研究[J]. 中华流行病学杂志,2022,43(12):1875-1880. DOI:10.3760/cma.j.cn112338-20220628-00572.
|